Current Clinical Trials
If you are interested in participating in or learning more about one of our clinical trials, please contact us at (212) 888-8516.A Phase 2 Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderate to Severe Diabetic Neuropathy and Unmeasurable Nerve Conduction Velocity
Read more about this clinical trial.
A Phase 2 Repeat Dosing Clinical Trial of SB-509 in Subjects with Diabetic Neuropathy
Read more about this clinical trial.
For information about our clinical trials, please contact:
Frances Di Clemente
E-mail: fmd2003@med.cornell.edu